Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Redpoint Bio, a developer of taste enhancers and aversive taste blockers, has signed an agreement to collaborate with Schering, a subsidiary of Schering-Plough, in the area of taste science research for pharmaceutical applications.
Subscribe to our email newsletter
This expanded feasibility agreement builds upon the successful completion of a previous research study between the parties. Scope and terms of the agreement were not disclosed.
Ray Salemme, CEO of Redpoint Bio, said: “We are extremely pleased to have expanded our research collaboration with Schering. We believe this agreement is a further endorsement of Redpoint Bio’s unique taste science platform and it’s applicability to pharmaceutical development. We look forward to continuing our good working relationship with the Schering team.”